ASEP Medical Holdings, Inc. engages in the acquisition of assets, technology, and businesses in the area of life sciences and medical diagnostics. The company is headquartered in Victoria, British Columbia. The company went IPO on 2021-11-22. The firm consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. The firm offers a rare combination of both a novel diagnostic and a therapeutic approach. The Company’s lead product was developed through its subsidiary, Sepset Biosciences Inc., which utilizes proprietary diagnostic tools to enable the early and timely identification of sepsis. ABT Innovations Inc. provides broad-spectrum therapeutic agents to address multi-drug resistant biofilm infections. SafeCoat Medical Inc. provides an antimicrobial peptide, anti-fouling medical device coating technology.
Follow-Up Questions
¿Quién es el CEO de Asep Medical Holdings Inc?
Dr. Robert Hancock es el Chief Executive Officer de Asep Medical Holdings Inc, se unió a la empresa desde 2021.
¿Qué tal es el rendimiento del precio de la acción SEPSF?
El precio actual de SEPSF es de $0, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Asep Medical Holdings Inc?
Asep Medical Holdings Inc pertenece a la industria N/A y el sector es N/A
¿Cuál es la capitalización bursátil de Asep Medical Holdings Inc?
La capitalización bursátil actual de Asep Medical Holdings Inc es $0
